Oura makes a wearable ring that collects biometric signals and translates them into health insights via the Oura App. Its platform surfaces patterns in sleep, activity, physiological stress and recovery to help members understand how behaviors and routines affect health. The company recently introduced GLP-1 Insights, which lets members log medication use and compare it to biometric trends; over 100,000 members have recorded GLP-1 use in the app. Oura positions its product to support continuous monitoring between clinical visits and to inform long-term care journeys for chronic conditions. The company received an undisclosed equity investment from Eli Lilly to accelerate development of more personalized, connected health experiences.

Total raised

$1.2B

Funding rounds

9

Latest round

Series E

Latest activity

Sep 2025